Study Design: In all, 69 premature infants born at <33 weeks gestation were randomly assigned to one of the two treatment groups: (1) No-Sting or (2) Aquaphor for a total of 14 days.
Introduction
Premature infants experience frequent complications related to skin immaturity. Their underdeveloped epidermis and stratum corneum inhibit the skin's ability to regulate body temperature, maintain water and electrolyte balance, prevent infection and protect against absorption of toxic substances. [1] [2] [3] [4] [5] [6] [7] [8] In addition, the thin premature infant skin is characterized by increased insensible water loss and frequent skin breakdown. 2, 5, [9] [10] [11] [12] [13] Premature skin is most fragile for 2 weeks after birth, especially in very immature infants (23 to 25 weeks). 5, 6, 12, 14 This is exacerbated by the use of skin probes and leads that can damage the skin. 4, 5, 8, 13, 15 A variety of skin care practices have been used to ameliorate these problems, including increased humidity and the use of emollients such as Aquaphor. The use of emollients has been shown to protect premature infant skin and prevent it from tearing or stripping, 7, [16] [17] [18] [19] and has also been associated with an increased risk of nosocomial sepsis. 16, 20 However, the acceptability of emollients is low because of the difficulty in affixing leads and temperature probes.
No-Sting is a hypoallergenic, non-cytotoxic liquid film that will not sting even when applied to damaged or denuded skin. 21, 22 It comprises water, plastic polymers and odorless non-alcohol evaporating agents. Although the evaporating agents are not felt to be harmful with contact to the skin, care should be taken to cover the face to avoid inhalation of the product during application. There are no data regarding No-Sting's use on premature infant skin and it is not currently approved by the Food and Drug Administration for infants <30 days of age; however, its nontoxic nature, 22 effectiveness in adult wound care 21, 23 and ease of application make this product an appealing option for protecting fragile premature skin.
The purpose of this study was to compare the effects of No-Sting skin protectant and Aquaphor on transepidermal water loss (TEWL) and skin integrity over the first 2 weeks of life in premature infants (<33 weeks gestation). The following research questions were addressed: (1) Are there any differences in neonatal skin condition scores between skin treated with No-Sting versus Aquaphor? and (2) Are there any differences in TEWL between skin treated with No-Sting versus Aquaphor?
Methods

Study design
Over 18 months, 69 infants born at <33 weeks gestation were enrolled after parental consent at <48 h of age. Infants were stratified according to gestation, <28 weeks or 29 to 33 weeks, and randomly assigned using a computer-generated list to one of the two treatment groups: No-Sting or Aquaphor. Infants were excluded from study participation if they had a congenital skin disease, skin rash, an initial Neonatal Skin Condition Score (NSCS) 24 of X5 (poor skin condition) or known maternal HIV infection. This study was conducted in the intensive care nurseries at Duke University Hospital in Durham, North Carolina, and Brenner Children's Hospital in Winston-Salem, North Carolina. The study was approved by the institutional review boards of both institutions. Out of 69 infants, three (1 No-Sting and 2 Aquaphor) were withdrawn from the study after 6 days because of severity of illness or transfer to another institution.
Intervention
The intervention was initiated as soon as feasible after birth with all treatments beginning by 48 h of age. Infants received the skin care treatment for 2 weeks (No-Sting or Aquaphor) on the trunk, arms and legs, excluding the perineal area. Infants assigned to the No-Sting group had the front of the trunk, arms and legs sprayed and allowed to dry for 30 s. The infant was then turned and the back of the trunk, arms and legs were sprayed in a similar manner. A second application was administered using the same procedure at 7 days after the first application. During each application, a cloth diaper placed over the infant's face prevented any vapor from potentially entering the infant's airway and/or eyes. Although daily applications of No-Sting are recommended to protect skin from repeated exposure to urine or stool, it was expected that one application weekly for the first 2 weeks of life would be adequate to minimize water loss and maintain skin integrity.
Infants in the Aquaphor group received an individual-use tube for twice daily applications. Using sterile gloves, a 1-inch ribbon of Aquaphor was applied over the infant's trunk, arms and legs from the neck distally. This application procedure was repeated twice daily. Both treatments were administered without any infant instability (for example, bradycardia) by nurses trained according to the study protocol. The intervention protocol continued for 14 days, at which time skin care resumed according to the unit guidelines.
Measures
Covariates. The medical record was reviewed and the following data were collected: infant gestational age, fluid intake, phototherapy use, urine output and serum sodium and potassium. Gestational age was based upon either the first day of the last menstrual period or an obstetric ultrasound to calculate the expected date of confinement.
The standard of care in both study sites was to provide supplemental humidity for infants with birth weights p1000 g for the first 2 weeks of life. Depending upon birth weight, 60 to 80% humidity level was provided for the first week of life and 40 to 60% humidity was provided for the second week of life (protocols available upon request). Humidity levels were measured at each assessment point with the DermaLab (Cortex Technology, Hadsund, Denmark; see TEWL below).
Neonatal skin condition. The skin condition was assessed daily for 14 days and the NSCS was recorded. 24 The NSCS is a 9-point scale that assesses the entire body in three domains: dryness, erythema and skin breakdown. Each domain is ranked on a scale of 1 to 3, with a total score of 3 being normal and 9 being the worst score possible. The NSCS has good intrarater (k ¼ 0.687 to 0.854) and interrater (k ¼ 0.659 to 0.89) reliability. In addition, infants with higher skin scores have a higher probability of having a documented infection. 24 Clinically scores of <4 are considered normal, 4 to 6 at risk and >6 poor skin condition.
Transepidermal water loss (TEWL). Transepidermal water loss was measured daily for 14 days using the DermaLab. [25] [26] [27] The Dermalab consists of an open probe with paired sensors placed at different distances from the skin. Humidity and temperature are measured in each sensor to calculate vapor pressure gradients. The difference between the two vapor pressure gradient measures is representative of TEWL at that point on the skin. 26, 27 The Dermalab measures TEWL from 0 to 250 g m À2 h À1 . TEWL measures were taken at two sites daily; the right shoulder and left thigh. Two different sites were chosen to measure TEWL because previous research showed that TEWL varied with body location. 28, 29 The thigh was chosen because the infant's leg was usually easily accessible regardless of the infant's position and the right shoulder was selected because it is not typically used as a site for any other monitors or equipment and could also be easily reached with minimal manipulation of the infant. 6 Environmental humidity levels were measured using the Dermalab with the paired sensors in the open probe before obtaining the TEWL measures. The average of the humidity readings from the two sensors was recorded as environmental humidity. Of the 1088 observations of TEWL, most infants were cared for in incubators (incubators, 93.0%; radiant warmers, 3.1; open crib 3.9%) with mean humidity levels between 46 and 55% (incubator, mean 55.1, s.d. 15.9; radiant warmer, mean 54.9, s.d. 15.8 ; open crib, mean, 46.5, s.d. 18.6. Humidity levels were also used as a covariate in each analysis of TEWL to ensure that observed treatment differences were not confounded with environmental humidity levels.
Data analyses
Power analyses for regression models using repeated measures were performed, allowing for correlational structures in addition to 30 A first-order autoregressive model indicated that standardized mean differences of 0.42 with power equal to 0.80 and a ¼ 0.05, two tailed were detectable. Effects of this magnitude are considered 'medium-sized' in the statistical literature. 31 Statistical models, referred to as mixed models, 32, 33 hierarchical linear models 34 and multilevel models, 35 were used to answer the research questions. With this approach, each subject's repeated measures on a dependent variable are first parameterized as an individual growth trajectory plus an error term. In a second stage, the estimated trajectories are modeled as a function of the differences between individuals on independent variables of interest. For analysis of TEWL, SAS PROC MIXED (SAS Institute, Cary, NC, USA) 36 was used to estimate the mixed models. Because SAS does not provide procedures to estimate multilevel ordinal logistic models, the STATA-based procedure GLLAMM (University of London, London, England) 37 was used for the one ordinal outcome (NSCS).
Results
In initial analyses, several variables were examined to determine whether despite randomization, they were over-represented in a treatment group. Study site, day of life entering the study, gestational age at birth, birth weight, gender, race, type of birth (vaginal vs cesarean), Apgar scores, admitting diagnosis and incidence of sepsis were similar across the treatment groups. Table 1 includes descriptive characteristics of each group.
Ten infants had a diagnosis of late-onset sepsis; defined as a positive blood culture drawn after 3 days of life that was treated with antibiotics for at least 5 days. Six infants (15.8%) in the No-Sting and 4 infants (12.9%) in the Aquaphor had positive cultures. Out of 10 infants, 7 were born at p28 weeks gestation, and the other three infants were each born at 31 weeks gestation and were in the Aquaphor treatment group. The study was not powered to evaluate differences in the incidence of sepsis between the two treatment groups.
Neonatal skin condition
The total NSCS for the three domains (dryness, erythema and skin breakdown) ranged between 3 and 6. In all, 73% of the NSCS in both groups were scored a normal value of 3, 22% scored 4, 4% scored 5 and only 1% scored 6. Figure 1a presents observed means over the 14 days of treatment. The results of significance tests, based on the multilevel regression models described above, are in Table 2 . For NSCS, the exponentiated logistic odds ratio coefficients indicate multiplicative change in the odds of an increase in the NSCS per unit change in the predictor. The observed means indicate that a decline in NSCS over time was slightly steeper in the Aquaphor group. The regression results show a significant group by time interaction effect with the effect of time on NSCS equal to odds ratio ¼ 1.02 in the No-Sting group compared with 0.81 in the Aquaphor group. Of the three NSCS domains (redness, dryness and skin breakdown), the dryness scores of 2 contributed to the higher skin condition scores in the No-Sting group. Among the covariates, gestational age was negatively related to NSCS (odds ratio ¼ 0.66), whereas total daily fluid intake was positively related to skin condition (odds ratio ¼ 1.11; see Figure 1a ).
Transepidermal water loss (TEWL)
Transepidermal water loss was measured at two sites: the left thigh and the right shoulder. TEWL data for the left thigh, observed means and regression results are given in Figure 1b . The regression coefficients are unstandardized regression b's indicating additive change in TEWL per unit change in a predictor (see Table 2 ). The observed means indicate similar change over time (days of intervention) by treatment group (Figure 1b) , and the regression results reflect this pattern, indicating significant decline over time (P<0.02) but no significant group effect or group by time interaction. Infants of older gestational ages (b ¼ À3.77) and cared for in higher humidity (b ¼ À0.09) had lower TEWL, but increases in total fluid intake (b ¼ 0.07) were related to higher TEWL. Figure 1c presents observed means for TEWL data for the right shoulder. In general, both treatment groups show initial steep decline, which begins to level off after day 10. Although overall mean decline seems fairly similar across treatment groups, decline is steeper in the No-Sting group from day 2 through day 4 (largely because of higher initial values), whereas those in the Aquaphor No-Sting protectant and Aquaphor DH Brandon et al group (but not those in the No-Sting group) increased TEWL between days 10 and 13. These differences are reflected in the significant group by time interactions (Table 2 ). For the No-Sting group, initial decline is À2.63, whereas the average increase in the rate of decline is 0.11 per day. For the Aquaphor group, the comparable estimators are (À2.63 þ 1.55 ¼ À1.08) and (0.11-0.07 ¼ 0.04). Similar to the left thigh, gestational age was negatively related to TEWL (b ¼ À198).
In additional analyses (available upon request), the group by humidity and the group by total fluid interactions were tested. The results were negative for total fluids and ambiguous for humidity, with results dependent upon the residual covariance used and whether the dependent variable was analyzed in logged versus raw form. A high zero-order correlation between humidity and gestational age (À0.58) likely introduced collinearity into the model and accounted, at least in part, for these unstable results. No-Sting protectant and Aquaphor DH Brandon et al
Discussion
Previous research with premature infants has shown increased skin integrity and decreased TEWL with use of emollients in the first few days of life. 7, 17 The increased risk of infection associated with emollients has limited their use; 16, 38 yet, care practices that promote skin integrity are essential to prevent fluid and electrolyte imbalance and minimize risk of nosocomial infections from epidermal stripping. In this study, the neonatal skin condition scores for infants receiving Aquaphor were statistically better than those for infants receiving No-Sting, but infants in both groups had normal skin scores, and few infants in either group had any skin breakdown (breakdown domain scores of 2 or 3). Of the three skin domains (redness, dryness and skin breakdown), dryness scores of 2 contributed to the higher skin condition scores in the No-Sting group. The loss of moisturization in skin makes the skin at risk for cracking and skin breakdown. 39, 40 . The application of No-Sting creates a dry layer of skin protectant that makes normal skin look dry. In contrast, emollients make the skin look slick and moist. It is likely that the product, rather than the condition of the skin, contributed to the observed differences in skin condition scores, and the underlying health of the skin was similar.
Previous research has shown that emollients significantly reduce TEWL. 7, 41 In this study, TEWL declined significantly over time in both intervention groups, as would be expected. 5, 6, 29, 42 . In addition, infants at older gestational ages had significantly less water loss. 29 Given that there were no observed differences in TEWL between infants receiving No-Sting and Aquaphor, this would suggest that No-Sting is as effective as Aquaphor in minimizing TEWL.
In this study, both Aquaphor and No-Sting were able to maintain normal skin condition scores and decrease TEWL. No-Sting's ease of application (only twice in 2 weeks compared with Aquaphor's twice daily for 2 to 4 weeks) makes it more favorable to nursing staff, and allows fragile neonates to be left alone and minimally stimulated. However, given the concern over the risk for nosocomial infections with emollients, 16, 20 future research should analyze the risk of nosocomial infections with No-Sting. This study was not adequately powered to address this issue.
Similar to previous research, infants cared for in higher humidity in this study had significantly less TEWL. 28, 29, 42, 43 The skin of a premature infant makes up about 13% of the body weight and comprises 80 to 90% of water in infants of <26 weeks gestation. 44, 45 For every 1 ml of water lost through a premature infant's skin, 560 calories of heat are produced. Therefore, it is difficult to maintain temperature stability in infants with high TEWL, 1 and growth is compromised because of the energy used in heat production. Although humidity decreases TEWL, it has also been related to decreased skin maturation at 4 weeks of age. 42 As many infants in this study were cared for in >50% of humidified environments during the first week of life, it is possible that the long-term skin condition of these infants may have been influenced by the humidity.
This study has provided preliminary evidence for the effectiveness of No-Sting on premature infant skin to minimize water loss and maintain skin integrity. Future research should explore both the short-and long-term effects of No-Sting and humidity on TEWL, skin condition and skin maturation. Interventions designed to maintain skin integrity and minimizing TEWL will promote growth, maintain fluid and electrolyte balance and prevent infections.
